Latest Trials

EudraCT Number: 2005-001614-41 Sponsor Protocol Number: CSTI571BIT06 Start Date: 2005-05-19
Sponsor Name: NOVARTIS FARMA
Full Title: OPEN-LABEL TRIAL OF GLIVEC IMATINIB MESYLATE IN PATIENTS WITH REFRACTORY DESMOPLASTIC SMALL ROUND CELL TUMORS DSRCT EXPRESSING A MOLECULAR TARGET OF GLIVEC PDGF-R AND/OR C-KIT
Medical condition: TREATMENT OF PATIENTS WITH REFRACTORY DESMOPLASTIC SMALL ROUND CELL TUMORS DSRCT .
Disease: Version SOC Term Classification Code Term Level
6.1 10039491 PT
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-004042-41 Sponsor Protocol Number: D5890C00003 Start Date: 2005-05-18
Sponsor Name: AstraZeneca AB
Full Title: A comparison of the inflammatory control of asthma provided by one inhalation of Symbicort® Turbuhaler® 160/4.5 µg/inhalation b.i.d. plus as-needed versus one inhalation of Symbicort® Turbuhaler® 3...
Medical condition: This is a Phase IIIB trial to be conducted in adult asthmatic patients.
Disease: Version SOC Term Classification Code Term Level
10003553
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed) SE (Completed) GB (Completed) ES (Completed) DK (Completed)
Trial results: View results
EudraCT Number: 2005-000897-38 Sponsor Protocol Number: DAM/001/05 Start Date: 2005-05-18
Sponsor Name: FARMACEUTICI DAMOR
Full Title: Open-label, controlled, randomised, multicentre, parallel group clinical trial of efficacy and tolerability of Fitostimoline soaked gauzes, Fitostimoline cream and Citrizan gel in the topical...
Medical condition: Topical treatment of second-degree superficial cutaneous burns
Disease: Version SOC Term Classification Code Term Level
6.1 10006802 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003975-35 Sponsor Protocol Number: 750201.01.014 Start Date: 2005-05-18
Sponsor Name: Dr. Willmar Schwabe GmbH & Co. KG
Full Title: Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with restlessn...
Medical condition: restlessness and sleep disturbances MedDRA Code for RESTLESSNESS: 10038743 MedDRA Code für SLEEP DISTURBANCES: 10040997
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-001371-35 Sponsor Protocol Number: S241-GB-03 Start Date: 2005-05-18
Sponsor Name: Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division)
Full Title: A Double-Blind, Placebo Controlled, Half-Head Design, CPO Solution Dose Ranging-Finding Study in Patients with Seborrhoeic Dermatitis of the Scalp
Medical condition: Seborrhoeic dermatitis
Disease: Version SOC Term Classification Code Term Level
8.0 10039793 LLT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000192-17 Sponsor Protocol Number: GO-80, V1 18 Mar 05 Start Date: 2005-05-18
Sponsor Name: Barts & The London NHS Trust
Full Title: Gemcitabine and Oxaliplatin in the treatment of locally advanced or metastatic transitional cell carcinoma of the urinary tract in patients with impaired renal function and patients who have progr...
Medical condition: Locally advanced or metastatic transitional cell carcinoma of the urinary tract
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2005-000685-39 Sponsor Protocol Number: 2005-1 Start Date: 2005-05-18
Sponsor Name: Universitetssjukhuset Örebro
Full Title: Postoperativ smärtlindring och mobilisering efter per- och postoperativ injektion av ropivakin, ketorolak och adrenalin givet i operationsområdet, infiltrativt och i knäleden, vid enkammarknäplasti...
Medical condition: Post-operativ smärta efter enkammarknäplastikoperation, s k miniknä
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-005122-45 Sponsor Protocol Number: D1441L00032 Start Date: 2005-05-18
Sponsor Name: AstraZeneca GmbH
Full Title: RACE : Rapid Dose Escalation of Quetiapine versus Conventional Escalation in the Treatment of Patients with Acute Schizophrenia – a Multicentre, Double-blind, Parallel group, Randomized Study
Medical condition: Patients hospitalised with a DSM-IV diagnosis of schizophrenia showing acute agitation and psychosis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-000535-18 Sponsor Protocol Number: ML17632 Start Date: 2005-05-18
Sponsor Name: Roche Pharma (Schweiz) AG
Full Title: Prospective, multicenter study to evaluate the renal safety of 6 mg ibandronic acid infusions over 15 min or 60 min in patients with metastatic bone disease due to breast cancer.
Medical condition: The target population for this trial are female patients with primary breast cancer with metastatic bone disease.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000959-15 Sponsor Protocol Number: HOE901/4057 Start Date: 2005-05-17
Sponsor Name: sanofi-aventis
Full Title: A multicenter clinical trial to evaluate quality of life in patients with Type 2 diabetes before and after changing therapy to a combination of insulin glargine and oral antidiabetic drugs in a rea...
Medical condition: Patients with Type 2 diabetes inadequately controlled on a combination of highest tolerable dose of oral antidiabetic drugs (OAD) + neutral protamine hagedorn (NPH) insulin for more than 3 months
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe